title: Surface plasmon resonance in doping analysis.
abstract: Doping analysis relies on the determination of prohibited substances that should not be present in the body of an athlete or that should be below a threshold value. In the case of xenobiotics their mere presence is sufficient to establish a doping offence. However, in the case of human biotics the analytical method faces the difficulty of distinguishing between endogenous and exogenous origin. For this purpose ingenious strategies have been implemented, often aided by state-of-the-art technological advancements such as mass spectrometry in all its possible forms. For larger molecules, i.e. protein hormones, the innate structural complexity, the heterogeneous nature, and the extremely low levels in biological fluids have rendered the analytical procedures heavily dependent of immunological approaches. Although approaches these confer specificity and sensitivity to the applications, most rely on the use of two, or even three, antibody incubations with the consequent increment in assay variability. Moreover, the requirement for different antibodies that separately recognise different epitopes in screening and confirmation assays further contributes to differences encountered in either measurement. The development of analytical techniques to measure interactions directly, such as atomic force microscopy, quartz crystal microbalance or surface plasmon resonance, have greatly contributed to the accurate evaluation of molecular interactions in all fields of biology, and expectations are that this will only increase. Here, an overview is provided of surface plasmon resonance, and its particular value in application to the field of doping analysis.
authors: Neuropsychopharmacology Program, IMIM-Hospital del Mar, Barcelona, Spain. rgutierrez@imim.es
authors: R
authors: R
authors: Gutiérrez-Gallego
authors: E
authors: E
authors: Llop
authors: J
authors: J
authors: Bosch
authors: J
authors: J
authors: Segura
mesh_terms: D004300:Doping in Sports; D006801:Humans; D007118:Immunoassay; D036361:Peptide Hormones / Q000032:analysis* / Q000276:immunology; D012680:Sensitivity and Specificity; D015813:Substance Abuse Detection / Q000379:methods*; D020349:Surface Plasmon Resonance
chemical_list: D036361:Peptide Hormones